State Drug Advertising Laws Foreshadow Future Device Regulation
This article was originally published in The Pink Sheet Daily
Executive Summary
Some state lawmakers contend that industry's voluntary code of ethics is insufficient, according to Kyphon's chief compliance officer.
You may also be interested in...
J&J Sues Boston Scientific, Abbott For $5.5 Bil For Breach Of Contract
After losing bidding war for Guidant, J&J charges winning firms with using leaked information.
FDA Official Distinguishes Scientific Exchange From Off-Label Promotion
Agency compliance head Tim Ulatowski says he's not concerned about the scientific exchange of information on products.
Supreme Court Considers Patentability Of Basic Scientific Relationship
Defendant Metabolite argued that validity of patenting a natural phenomenon would have broader implications within the pharmaceutical, device and diagnostics industries.